Clinical Trial Update: A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients [Phase 1]

View source ↗

Summary

Update on a Phase 1 clinical trial evaluating adoptive transfer of autologous NKT cells in patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous NKT cell therapy (autologous natural killer T (NKT) cells)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma | Phase 1 | Status: UNKNOWN